Post by
stargazer1 on Jan 10, 2024 2:32pm
Next press release should be good. LowMoor, a question
From the press releases that have been released, all results are positive. The next press release will probably be an update on how the trials are progressing. If it is better than expected, the stock could edge up some. As the patient trials progress and continue to show positive results, the price rise will accellerate.
LowMoor I have a question. I have been trying to find a site that shows NGENF insider trades. Every site that I have found says that they have no informatio on insider trading.
Where did you find your information? Is it your brokerage site? Or a site where you have to pay? I am willing to pay for a site.
Thanks.
I am holding NGENF for the long haul. If they can cause damaged neurons to recover, or new ones to replace them, this could go to several hundred dollars a share, or even be one of the $1,000 stocks. Although long before that, it would probably be bought by one of the giant pharm companies. But, even so, they would pay big bucks to acquire our company.